Evercore ISI Group Maintains Outperform on TransMedics Group, Raises Price Target to $170
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Evercore ISI Group analyst Daniel Markowitz maintains TransMedics Group (NASDAQ:TMDX) with a Outperform and raises the price target from $155 to $170.
Evercore ISI Group analyst Daniel Markowitz maintains TransMedics Group (NASDAQ:TMDX) with a Outperform and raises the price target from $155 to $170.